Sharps Technology INC 8-K filings

Sharps Technology enters into a cooperative sales and distribution agreement with Roncadelle Operations s.r.l. and a logistics agreement with Owens & Minor, while terminating its previous distribution agreement with Nephron Pharmaceuticals.

Sharps Technology and Roncadelle Operations have partnered to expand the global reach of their innovative safety syringe product lines.

Sharps Technology has been granted a second 180-day extension, until July 8, 2024, to regain compliance with Nasdaq's minimum bid price requirement.

Sharps Technology and Roncadelle Operations have signed a Letter of Intent to collaborate on sales and distribution, expanding their reach into new global markets.